| [606] COMPARISON OF PEGINTERFERON a-2a AND RIBAVIRIN FOR 12 OR 24 WEEKS IN PATIENTS WITH HCV GENOTYPE 2/3: THE NORDYNAMIC TRIAL M Lagging, C Pedersen, MR Buhl, M Farkkila, N Langeland, K Morch, ... Journal of Hepatology, S229, 2007 | 6 | 2007 |
| 10 RIBAVIRIN CONCENTRATION AT WEEK FOUR IS AN INDEPENDEND PREDICTOR FOR SUSTAINED VIROLOGICAL RESPONSE AFTER TREATMENT OF HEPATITIS C GENOTYPE 2/3 (NORDYNAMIC TRIAL) PB Christensen, AA Alsio, MR Buhl, M Farkkila, K Morch, P Sangfelt, ... Journal of Hepatology, S6-S7, 2008 | 11 | 2008 |
| 317 International multicenter, randomized, controlled study comparing standard versus dynamically individualized treatment in patients with chronic hepatitis C (DITTO-HCV) project S Zeuzem, JM Pawlotsky, E Hagai, I Goulis, Y Lurie, E Gianfranco, ... Hepatology, 310, 2003 | 7 | 2003 |
| 408 EVALUATION OF THE ROUTINE MEDICAL INTERVIEW TO IDENTIFY HEPATITIS C PATIENTS DEVELOPING MAJOR DEPRESSION DURING PEGINTERFERON ALFA-2A PLUS RIBAVIRIN TREATMENT USING THE … P Leutscher, M Buhl, M Lagging, C Pedersen, Å Alsiö, G Norkrans, ... Journal of Hepatology, S154, 2009 | | 2009 |
| 494 Analysis of peripheral HCV-specific T cell responses associated with rapid viral decline during PEG-interferon-alfa-2A and ribavirin therapy (DITTO-HCV project) G Missale, M Pilli, A Zerbini, A Penna, A Orlandini, A Neumann, ... Journal of Hepatology, 145-146, 2004 | 1 | 2004 |
| 620 Presence of CD4-positive cells in the portal tract on pretreatment liver biopsy is associated with early viral reduction during antiviral treatment of HCV J Westin, M Lagging, A Romero, G Norkrans, JM Pawlotsky, A Neumann, ... Journal of Hepatology, S230-S231, 2006 | | 2006 |
| 839 TWELVE WEEKS OF TREATMENT IS INSUFFICIENT FOR HCV GENOTYPE 2 AND 3 INFECTED PATIENTS WITH STEATOSIS J Westin, M Lagging, C Pedersen, MR Buhl, M Farkkila, N Langeland, ... Journal of Hepatology, S314-S315, 2008 | 2 | 2008 |
| 885 INTRAHEPATIC MRNA LEVELS OF THE SUPPRESSORS OF CYTOKINE SIGNALLING 1 AND 3 ARE ASSOCIATED WITH CIRRHOSIS BUT NOT WITH TREATMENT RESPONSE IN CHRONIC HEPATITIS C S Clement, S Pascarella, MT Dill, S Conzelmann, M Lagging, G Missale, ... Journal of Hepatology, S344, 2012 | | 2012 |
| A model explaining the correlations between IL28B-related genotypes, hepatitis C virus genotypes, and viral RNA levels M Lindh, M Lagging, G Norkrans, K Hellstrand Gastroenterology 139 (5), 1794-1796, 2010 | 24 | 2010 |
| A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection J Westin, M Ydreborg, S Islam, Å Alsiö, AP Dhillon, JM Pawlotsky, ... Scandinavian journal of gastroenterology 43 (1), 73-80, 2008 | 45 | 2008 |
| A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis M Ydreborg, V Lisovskaja, M Lagging, P Brehm Christensen, ... PLoS One 9 (4), e93601, 2014 | 10 | 2014 |
| A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel M Cornberg, HA Razavi, A Alberti, E Bernasconi, M Buti, C Cooper, ... Liver International 31, 30-60, 2011 | 590 | 2011 |
| Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection J Waldenström, M Kåberg, M Alanko Blome, A Widell, P Björkman, ... Scandinavian Journal of Gastroenterology 56 (7), 855-861, 2021 | | 2021 |
| Acute exacerbation of chronic hepatitis B: Yet another incentive to commence universal infant immunization even in low endemic areas M Lagging Scandinavian journal of gastroenterology 43 (2), 131-131, 2008 | 1 | 2008 |
| Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories D Razavi-Shearer, H Child, K Razavi-Shearer, A Voeller, H Razavi, M Buti, ... Journal of Hepatology 80 (2), 232-242, 2024 | 5 | 2024 |
| Antibodies to Ncore of Morbilli virus in patients with MS and their siblings with trait L Persson, S Longhi, O Andersen, M Lagging, M Johansson, J Enarsson, ... EUROPEAN JOURNAL OF MEDICAL RESEARCH 15, 141-141, 2010 | | 2010 |
| Are FoxP3+ cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C? J Westin, K Hellstrand, AP Dhillon, M Lagging, DITTO‐HCV Study Group Journal of Viral Hepatitis 18 (2), 149-151, 2011 | 1 | 2011 |
| Association between an index of standard biochemical serum markers, viral kinetics, and therapeutic outcome with peginterferon alpha-2a combination therapy in patients with … M Lagging, J Westin, A Romero, K Hellstrand, G Norkrans, R Wejstal, ... JOURNAL OF HEPATOLOGY 42, 209-209, 2005 | | 2005 |
| Association between interleukin-28B-related genetic variants and liver histopathology differs between hepatitis C virus genotypes. LM Rembeck K, Westin J, Lindh M, Hellstrand K, Norkrans G, ... Hepatology 56 (1), 394, 2012 | 12 | 2012 |
| Association between liver histology, viral kinetics and outcome of therapy with peginterferon alpha-2a combination therapy with ribavirin in interferon naive patients with … M Lagging, J Westin, P Dhillon, A Romero, K Hellstrand, G Norkrans, ... JOURNAL OF HEPATOLOGY 42, 209-209, 2005 | 1 | 2005 |
Bart L. HaagmansDepartment of Viroscience, Erasmus MC, RotterdamVerified email at erasmusmc.nl